Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stipo Jurcevic

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Transplantation|November 18, 2011
Role of the Fc region in CD70-specific antibody effects on cardiac transplant survivalHina Shariff, Roseanna E Greenlaw, Lucy Meader, et al.
Platelets|August 21, 2014
The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell diseaseJoseph A Jakubowski, Chunmei Zhou, Kenneth J Winters, et al.
Journal of Clinical Pharmacology|July 14, 2016
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy VolunteersGreg Coffey, Aradhana Rani, Andreas Betz, et al.
Plos One|February 2, 2013
Molecular analysis of precursor lesions in familial pancreatic cancerTatjana Crnogorac-Jurcevic, Claude Chelala, Sayka Barry, et al.
Nature Medicine|September 23, 2003
Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockadeNicola J Monk, Roseanna E G Hargreaves, James E Marsh, et al.
Thrombosis Research|December 26, 2013
A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulationJoseph A Jakubowski, Chunmei Zhou, Stipo Jurcevic, et al.
British Journal of Clinical Pharmacology|November 23, 2012
A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivityJoseph A Jakubowski, Chunmei Zhou, David S Small, et al.
International Immunopharmacology|April 5, 2008
Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteersTimothy G K Mant, Svetlana Borozdenkova, Daniel B A Bradford, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2011
The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challengeGrant C Nicholson, Harsha H Kariyawasam, Andrew J Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2011
IL-2 regulates expression of C-MAF in human CD4 T cellsAradhana Rani, Behdad Afzali, Audrey Kelly, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Transplantation|November 18, 2011
Role of the Fc region in CD70-specific antibody effects on cardiac transplant survivalHina Shariff, Roseanna E Greenlaw, Lucy Meader, et al.
Platelets|August 21, 2014
The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell diseaseJoseph A Jakubowski, Chunmei Zhou, Kenneth J Winters, et al.
Journal of Clinical Pharmacology|July 14, 2016
PRT062607 Achieves Complete Inhibition of the Spleen Tyrosine Kinase at Tolerated Exposures Following Oral Dosing in Healthy VolunteersGreg Coffey, Aradhana Rani, Andreas Betz, et al.
Plos One|February 2, 2013
Molecular analysis of precursor lesions in familial pancreatic cancerTatjana Crnogorac-Jurcevic, Claude Chelala, Sayka Barry, et al.
Nature Medicine|September 23, 2003
Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockadeNicola J Monk, Roseanna E G Hargreaves, James E Marsh, et al.
Thrombosis Research|December 26, 2013
A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulationJoseph A Jakubowski, Chunmei Zhou, Stipo Jurcevic, et al.
British Journal of Clinical Pharmacology|November 23, 2012
A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivityJoseph A Jakubowski, Chunmei Zhou, David S Small, et al.
International Immunopharmacology|April 5, 2008
Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteersTimothy G K Mant, Svetlana Borozdenkova, Daniel B A Bradford, et al.
The Journal of Allergy and Clinical Immunology|July 2, 2011
The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challengeGrant C Nicholson, Harsha H Kariyawasam, Andrew J Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2011
IL-2 regulates expression of C-MAF in human CD4 T cellsAradhana Rani, Behdad Afzali, Audrey Kelly, et al.
Pageof 3